Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2018

Jan 10, 2018

34519_dirs_2018-01-10_aa545982-75be-4783-add2-c67edba6a772.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2018-01-08

Reporting Person: Williams Elizabeth Luttrell (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-08 Incentive Stock Options (Right to buy) $7.8000 A 7500.0000 Acquired 2028-01-08 Common Stock (7500.0000) Direct